Financial results - HEBE-PHARM SRL

Financial Summary - Hebe-Pharm Srl
Unique identification code: 4169933
Registration number: J06/580/1993
Nace: 4773
Sales - Ron
829.740
Net Profit - Ron
123.622
Employee
10
The most important financial indicators for the company Hebe-Pharm Srl - Unique Identification Number 4169933: sales in 2023 was 829.740 euro, registering a net profit of 123.622 euro and having an average number of 10 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Hebe-Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 750.730 770.280 800.829 872.646 871.533 799.938 871.191 858.525 840.107 829.740
Total Income - EUR 809.345 826.741 824.421 894.473 926.346 899.983 922.440 895.525 840.121 1.029.550
Total Expenses - EUR 789.961 822.935 820.683 874.625 898.642 864.507 887.850 882.574 858.757 880.182
Gross Profit/Loss - EUR 19.384 3.806 3.739 19.848 27.704 35.475 34.590 12.951 -18.635 149.368
Net Profit/Loss - EUR 14.404 1.937 2.517 4.444 18.471 26.479 28.424 6.503 -24.844 123.622
Employees 11 11 13 14 13 11 11 11 10 10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -0.9%, from 840.107 euro in the year 2022, to 829.740 euro in 2023. The Net Profit increased by 123.622 euro, from 0 euro in 2022, to 123.622 in the last year.

Check the financial reports for the company - Hebe-Pharm Srl

Rating financiar

Financial Rating -
Hebe-Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Hebe-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hebe-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Hebe-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hebe-Pharm Srl - CUI 4169933

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 253.308 250.606 245.320 272.894 257.708 218.368 203.482 186.919 222.861 210.355
Current Assets 430.527 328.291 301.605 335.348 324.930 316.138 408.887 423.319 379.175 314.005
Inventories 204.082 215.950 228.630 197.448 180.741 197.591 212.754 213.048 220.815 171.850
Receivables 184.895 52.835 47.106 113.106 137.598 107.053 173.766 190.261 136.689 130.777
Cash 41.550 59.506 25.869 24.794 6.591 11.494 22.367 20.010 21.670 11.378
Shareholders Funds 181.589 185.042 130.894 133.123 149.151 172.741 194.582 192.728 168.482 271.376
Social Capital 1.682 1.696 1.679 1.651 1.620 1.589 1.559 1.524 1.529 1.524
Debts 502.246 429.303 452.798 495.940 441.561 370.705 425.553 429.901 443.478 252.267
Income in Advance 0 0 0 0 0 0 0 0 0 716
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 314.005 euro in 2023 which includes Inventories of 171.850 euro, Receivables of 130.777 euro and cash availability of 11.378 euro.
The company's Equity was valued at 271.376 euro, while total Liabilities amounted to 252.267 euro. Equity increased by 103.405 euro, from 168.482 euro in 2022, to 271.376 in 2023. The Debt Ratio was 48.1% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Hebe-Pharm Srl

Comments - Hebe-Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.